These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28584853)

  • 1. The Presence of Human Immunodeficiency Virus-Associated Neurocognitive Disorders Is Associated With a Lower Adherence to Combined Antiretroviral Treatment.
    Kamal S; Locatelli I; Wandeler G; Sehhat A; Bugnon O; Metral M; Du Pasquier R; Gutbrod K; Cavassini M; Schneider MP;
    Open Forum Infect Dis; 2017; 4(2):ofx070. PubMed ID: 28584853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
    Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP
    AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replication.
    Vassallo M; Fabre R; Durant J; Lebrun-Frenay C; Joly H; Ticchioni M; DeSalvador F; Harvey-Langton A; Dunais B; Laffon M; Cottalorda J; Dellamonica P; Pradier C
    J Neurovirol; 2017 Apr; 23(2):216-225. PubMed ID: 27815816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aging, neurocognitive impairment and adherence to antiretroviral therapy in human immunodeficiency virus-infected individuals.
    Pinheiro CA; Mattos Souza LD; Motta JV; Kelbert EF; Martins CS; Souza MS; Pinheiro KA; Coelho FM; Pinheiro RT
    Braz J Infect Dis; 2016; 20(6):599-604. PubMed ID: 27789283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between asymptomatic and mild neurocognitive impairment and adherence to antiretroviral therapy among people living with human immunodeficiency virus.
    Awori V; Mativo P; Yonga G; Shah R
    South Afr J HIV Med; 2018; 19(1):674. PubMed ID: 29707383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-infected patients' beliefs about their chronic co-treatments in comparison with their combined antiretroviral therapy.
    Kamal S; Bugnon O; Cavassini M; Schneider MP
    HIV Med; 2018 Jan; 19(1):49-58. PubMed ID: 28815917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline Neurocognitive Functioning Predicts Viral Load Suppression at 1-Year Follow-Up Among Newly Diagnosed HIV Infected Patients.
    Shahani L; Salazar L; Woods SP; Hasbun R
    AIDS Behav; 2018 Oct; 22(10):3209-3213. PubMed ID: 29350337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virologically suppressed patients with asymptomatic and symptomatic HIV-associated neurocognitive disorders do not display the same pattern of immune activation.
    Vassallo M; Durant J; Lebrun-Frenay C; Fabre R; Ticchioni M; Andersen S; DeSalvador F; Harvey-Langton A; Dunais B; Cohen-Codar I; Montagne N; Cua E; Fredouille-Heripret L; Laffon M; Cottalorda J; Dellamonica P; Pradier C
    HIV Med; 2015 Aug; 16(7):431-40. PubMed ID: 25981452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening HIV-associated neurocognitive disorders (HAND) among HIV positive patients attending antiretroviral therapy in South Wollo, Ethiopia.
    Tsegaw M; Andargie G; Alem G; Tareke M
    J Psychiatr Res; 2017 Feb; 85():37-41. PubMed ID: 27821271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor function declines over time in human immunodeficiency virus and is associated with cerebrovascular disease, while HIV-associated neurocognitive disorder remains stable.
    M Elicer I; Byrd D; Clark US; Morgello S; Robinson-Papp J
    J Neurovirol; 2018 Aug; 24(4):514-522. PubMed ID: 29696578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between brain volumes and HAND in cART-naïve HIV+ individuals from Thailand.
    Heaps JM; Sithinamsuwan P; Paul R; Lerdlum S; Pothisri M; Clifford D; Tipsuk S; Catella S; Busovaca E; Fletcher JL; Raudabaugh B; Ratto-Kim S; Valcour V; Ananworanich J;
    J Neurovirol; 2015 Apr; 21(2):105-12. PubMed ID: 25604494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era.
    Kallianpur AR; Wang Q; Jia P; Hulgan T; Zhao Z; Letendre SL; Ellis RJ; Heaton RK; Franklin DR; Barnholtz-Sloan J; Collier AC; Marra CM; Clifford DB; Gelman BB; McArthur JC; Morgello S; Simpson DM; McCutchan JA; Grant I;
    J Infect Dis; 2016 Apr; 213(7):1065-73. PubMed ID: 26690344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A short tool to screen HIV-infected patients for mild neurocognitive disorders - a pilot study.
    Fasel D; Kunze U; Elzi L; Werder V; Niepmann S; Monsch AU; Schumacher R; Battegay M
    BMC Psychol; 2014; 2(1):21. PubMed ID: 25815192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-associated neurocognitive disorder and HIV-associated myelopathy in a patient with a preserved CD4, but high viral load-a rarely reported phenomenon: a case report and literature review.
    Ayele BA; Amogne W; Gemechu L
    BMC Infect Dis; 2020 Aug; 20(1):574. PubMed ID: 32758161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-associated neurocognitive disorder in a KwaZulu-Natal HIV clinic: A prospective study.
    Mogambery JC; Dawood H; Wilson D; Moodley A
    South Afr J HIV Med; 2017; 18(1):732. PubMed ID: 29568639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determining the Neurocognitive Status and the Functional Ability of Patients to Screen for HIV-Associated Neurocognitive Disorder (HAND).
    Agarwal R; Aujla RS; Gupta A; Kumar M
    Dement Neurocogn Disord; 2020 Mar; 19(1):19-27. PubMed ID: 32174047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Screening Strategy for HIV-Associated Neurocognitive Disorders That Accurately Identifies Patients Requiring Neurological Review.
    Bloch M; Kamminga J; Jayewardene A; Bailey M; Carberry A; Vincent T; Quan D; Maruff P; Brew B; Cysique LA
    Clin Infect Dis; 2016 Sep; 63(5):687-693. PubMed ID: 27325690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of aging on neurocognitive performance in previously antiretroviral-naive HIV-infected individuals on their first suppressive regimen.
    Coban H; Robertson K; Smurzynski M; Krishnan S; Wu K; Bosch RJ; Collier AC; Ellis RJ
    AIDS; 2017 Jul; 31(11):1565-1571. PubMed ID: 28471765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D deficiency is associated with neurocognitive impairment in HIV-infected subjects.
    Vergori A; Pinnetti C; Lorenzini P; Brita A; Libertone R; Mastrorosa I; Cicalini S; Antinori A; Ammassari A
    Infection; 2019 Dec; 47(6):929-935. PubMed ID: 31183805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.